Using clinical trial data and linked administrative health data to reduce the risk of adverse events associated with the uptake of newly released drugs by older Australians: a model process

Table 7 2000 Cohort / OA/RA morbidities with CVD or CVA or Renal morbidities

	OA/RA hospital diagnosis + cardiovascular hospital diagnosis		*Male* vs. *Female*	OA/RA hospital diagnosis + cerebrovascular hospital diagnosis		*Male* vs. *Female*	OA/RA hospital diagnosis + hospital diagnosis of renal disease		*Male* vs. *Female*
Age Group	Male	Female	%	Male	Female	%	Male	Female	%
65-69	42	34	55 : 45	6	6	50 : 50	6	14	30 : 70
70-74	78	70	53 : 47	20	11	65 : 35	18	10	64 : 36
75-79	79	123	39 : 61	22	36	38 : 62	30	27	53 : 47
80-84	77	154	33 : 67	29	37	44 : 56	33	40	45 : 55
85-99	91	218	29: 71	11	49	18 : 82	28	57	33 : 67
Sub-totals	367	599		88	139		115	148
	Patients = 966			Patients = 227			Patients = 263

ISSN: 1471-2458